The evolution of combination therapy of genitourinary rhabdomyosarcoma in children: a preliminary report.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D014565:Urogenital Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D014625:Vaginal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide